4 Steps for a Smooth Tech Transfer When Working with a CDMO

In our recent article with BioPharma Dive, Emergent's Shelly Buhay, Director of MS&T and Dan Perrin, Director of Manufacturing discuss four essential steps for an efficient tech transfer when working with a CDMO.

When developing a new drug product, quality, safety and timing are critical. A Contract Development and Manufacturing Organization (CDMO) can be a valuable partner to help mitigate risks, avoid missteps and control costs in the process. But the success of the partnership revolves around a key step: the technology transfer.

Read the Article

Webinar: Outsourced Pharma Capacity Update

Tara Lorenz, Director of Commercial Operations, presented Emergent's development and manufacturing capabilities and available...


May 4th Webinar: Rapid Readiness for Pandemic Response

Watch our latest webinar on the topic of how drug developers can maximize capacity, capabilities and expertise for pandemic...


Case Study Corner: Streamlining R&D to Manufacturing

Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible...